In my last article on Gadolinium based contrast agents (GBCAs), I discussed some of the side effects of these injections, which are administered to patients during a Magnetic Resonance Imaging (MRI) or Magnetic Resonance Angiography (MRA). While GBCAs have started to draw attention in the pharmaceutical products liability legal realm, they have … [Read more...]
Gadolinium Deposition Disease can Result from use of Contrast Agents During MRI & MRA Procedures
What are Gadolinium-Based Contrast Agents (GBCAs)? GBCAs are substances that are injected into patients during Magnetic Resonance Imaging (MRI) or Magnetic Resonance Angiography (MRA) in order to produce clearer radiology images. Here is a list of GBCAs that are currently approved by the FDA: Ablavar Dotarem Eovist Gadavist … [Read more...]